Navigation Links
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
Date:11/1/2008

doses 12 hours apart, the concentration of ANA598 in plasma 12 hours after the second dose was 83 ug/mL, which substantially exceeds the level predicted to display antiviral potency. The data will be presented in a late-breaker poster titled "Results of a Phase I Safety, Tolerability and Pharmacokinetic Study of ANA598, a Non-Nucleoside NS5B Polymerase Inhibitor, in Healthy Volunteers", at 1:00 p.m. PST on Monday, November 3.

ANA598 Preclinical Data at AASLD Meeting

In addition to the results of the Phase I healthy volunteer study, Anadys is presenting additional data on the preclinical profile of ANA598 at the AASLD Meeting on Tuesday, November 4.

-- In a poster titled "In Vitro Studies Demonstrate that Combinations of Antiviral Agents that Include HCV Polymerase Inhibitor ANA598 have the Potential to Overcome Viral Resistance", Anadys will present the results of in vitro studies that show ANA598 to be synergistic with interferon-alpha, the protease inhibitor telaprevir (VX-950), and the nucleoside polymerase inhibitor PSI-6130 (the active agent of R7128). These studies also show that ANA598 retains activity against mutants known to confer resistance to other classes of direct antivirals, including protease inhibitors, nucleoside inhibitors and non-nucleosides that bind at the thumb site. Genotypic mutations resistant to ANA598 will be shown to be fully susceptible to interferon-alpha, telaprevir (VX-950) and PSI-6130. Data will also be presented demonstrating synergy between ANA598 and cytokines induced by ANA773, Anadys' TLR7 agonist oral prodrug, also in development for hepatitis C. These data strongly support the potential for ANA598 to be used in combination with multiple other agents approved or under investigation for hepatitis C.

-- In a poster titled "Antiviral Efficacy of the HCV RNA Polymerase Inhibitor ANA598 in the Chimpanzee Model of HCV Infection", Anadys will present data showing that ANA598 exhibits a substantial antivir
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
2. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
3. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
11. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  Syneron Medical Ltd. (NASDAQ: ELOS ), ... its new PicoWay® device has received CE Mark indication ... pigmented lesions on any skin type. PicoWay is a ... 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay technology to ... trillionths of a second, known as picosecond pulses. Syneron ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), innovatore e ... disturbi respiratori del sonno (SDB) e altre patologie croniche ... contro il produttore Taiwanese di dispositivi medicali, APEX Medical ... indossare in testa, che violano i brevetti, utilizzate con ... della Corte Regionale Distrettuale di Monaco ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, Inc. ... Roger Crystal , MD as Vice President of Business ... Business Development Product Acquisition & Licensing team at G.E. ... business strategy and partnerships in the precision medicine space ... with biotechnology and pharmaceutical companies across the spectrum to ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
... online marketplace for medical equipment , is pleased to ... Medical Equipment Parts Finder service. As it is often ... for medical equipment and devices, MedWOW,s R&D staff developed this ... the parts they need through MedWOW,s standard parts and accessories ...
... China, Nov. 1, 2010 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain ... or the "Company"), the largest drugstore chain in China ... today that the company will report its third quarter ... the market opens. The Company will host ...
Cached Medicine Technology:MedWOW Adds Parts Finder Service and Enhances Business Model 2China Nepstar Chain Drugstore to Report Third Quarter 2010 Financial Results on November 17, 2010 2
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... to treat severe chronic migraine headaches led to significant ... in patients treated at Massachusetts General Hospital (MGH). ... Surgery report that more than half of 35 patients ... had headaches associated with compression of craniofacial nerves ... team,s paper has received advance online publication in the ...
(Date:7/28/2014)... Massachusetts (PRWEB) July 28, 2014 ... Summit Provider Exchange technology solution in ... integration efforts and support collaboration with their New ... bed acute-care medical center located in New Jersey, ... seasonal visitors with a variety of inpatient and ...
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... Michigan (PRWEB) July 28, 2014 The ... Drs. Harris, Birkhill, Wang, Songe and Associates, PC that ... and countless tomorrows to come. , The HBWS ... responsible for more than $2.5 million in donations. Through ... title sponsors for the Oakwood Women’s Healthcare Classic for ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... related to stomach like diarrhoea, food poisoning and indigestion ... this festive season. NHS Direct is// a telephone and ... 0845 46 47. ,Stomach ache, tooth ache ... during the festive period. ,NHS Direct got ...
... all the talk about going the extra mile to make ... a survey has revealed the disappointing// negativism prevailing in the ... ,Nearly 27% of Britons who responded to the survey by ... denied the strength of personal efforts in preventing the disease. ...
... uric acid might have a say in whether an elderly ... , ,The study published in the January issue of Neuropsychology, ... at 96 community-dwelling adults aged 60 to 92 years old. ... high-normal range, defined as 5.8 to 7.6 milligrams per deciliter ...
... teenage girls might want to have another look at ... ,According to recent studies, teenage girls who read articles ... more prone to resort to drastic weight reducing techniques ... those who don’t. ,The study, published in Pediatrics' ...
... been developed that can help predict the risk ... pleocytosis (presence of greater// number of white blood ... according to a study. ,Although ... and treating children with cerebrospinal fluid (CSF) pleocytosis, ...
... Ramadev is a busy man today; fielding complaints from the ... of being taken to court, from an NGO.// ... claimed to hold the key to curing AIDS by performing ... Ramadoss had earlier rubbished these statements, saying while he supported ...
Cached Medicine News:Health News:Drop That Glossy, Girl! 2Health News:Clinical Guidelines Help Identify Which Children at Risk of Bacterial Meningitis 2
... 2.2 offers extremely high resolution treatment capability ... an exceptionally wide 78° field of view. ... critical evaluation of the optic nerve head ... of the macula and disc. Redesigned to ...
... is excellent for critically evaluating and ... macular degeneration, retinal vascular occlusions, diabetic ... other retinal conditions. It is ideal ... conditions providing excellent magnification combined with ...
... 130° QuadrAspheric lens has grown in popularity ... preferred wide field fundus laser lens. Its ... advantage over competitive wide field lenses for ... of use. This lens is excellent for ...
... Wide Field Lens combines exceptional ... magnification. The enhanced double aspheric ... high resolution stereo views of ... These unique features make it ...
Medicine Products: